ARCHIVES

Markison leaving Bristol-Myers, two others promoted in reorganization.

This article is from The Cancer Letter archive.

Vol. 30 No. 05 | January 30, 2004

Download PDF Visit The Full Archive

Related Articles

Cancer center directors to develop blueprint for progress that’s “honest,” M.D. Anderson’s John Mendelsohn says.

November 23, 2005

FDA, Genentech Agree On Framework for Avastin Hearing June 28-29

April 8, 2011

Duke wins Avon-NCI funding.

October 31, 2003

NIH Seeking Nominations for Review Committees

February 23, 1979

ASCO Recommends Against Chemo In Stage II Colon Cancer

June 25, 2004

In Brief: Satcher Names CDC Director; POG Appoints Monaco To Data Monitoring Committee

September 10, 1993